查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1662852

2030 年兒科醫療保健市場預測：按治療類型、藥物類型、年齡層、適應症、應用、最終用戶和地區進行的全球分析

Paediatric Healthcare Market Forecasts to 2030 - Global Analysis By Treatment Type (Medications, Surgical Procedures, Preventive Care, Therapy and Other Treatment Types), Drug Type, Age Group, Indication, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球兒科醫療保健市場預計在 2024 年達到 147 億美元，到 2030 年將達到 200 億美元，預測期內的複合年成長率為 6.4%。

專業兒科保健部門為新生兒、嬰兒和 18 歲以下的青少年提供醫療、治療和預防服務。這包括新生兒護理、疫苗接種、疾病預防以及糖尿病、氣喘和先天性疾病等長期問題的診斷、治療和管理。營養諮詢和疫苗接種計劃是重要的預防干涉措施。小兒科、護士和專家與父母合作，提供個人化的照護。隨著遠端醫療、醫療技術和人工智慧診斷的發展，全球獲得優質兒科醫療保健的機會正在不斷改善。

根據觀察家研究基金會 2021 年 12 月發布的資料，印度約有 2 億營養不良人口。感染疾病仍是全球五歲以下兒童死亡的主要原因。

慢性病增多

氣喘、糖尿病和肥胖症等兒童慢性疾病需要持續的諮詢和專門的護理，這增​​加了對兒科醫療保健服務的需求。此外，早期診斷和早期療育對於管理慢性病至關重要，這進一步凸顯了對先進診斷工具和治療方案的需求。家長對兒童定期健康檢查重要性的認知不斷提高，這也促進了市場的成長。

治療費用高且保險覆蓋範圍有限

對患有慢性或複雜疾病的兒童進行專門護理的費用可能非常昂貴，許多家庭無法負擔他們所需的護理。此外，並非所有保險計劃都完全涵蓋兒科醫療保健服務，導致家庭自付的費用高昂。與治療相關的經濟負擔使得父母無法為孩子獲得及時和適當的治療。改善保險覆蓋範圍和降低治療成本的治療方法對於確保所有兒童都能獲得優質的醫療保健至關重要。

提高對兒童健康和營養的認知

父母和照顧者越來越認知到均衡飲食、定期運動和預防性保健對孩子的重要性。這種日益增強的認知推動了對健康教育計劃、營養諮詢和健康服務的需求。學校和社區團體也在鼓勵兒童選擇健康的生活方式方面發揮作用。因此，兒科保健提供者正在擴大其服務範圍，包括針對兒童身體、心理和情緒健康的全面健康和保健計劃。

小兒科短缺

小兒科、小兒科護理師和其他專業醫療保健專業人員的需求日益成長，但供應卻無法滿足。這種短缺可能會導致預約等待時間更長、獲得專科護理的機會減少以及現有醫療保健提供者的業務增加。小兒科的短缺也可能影響兒童護理的質量，特別是那些患有複雜疾病且需要專業知識的兒童，從而阻礙市場成長。

COVID-19 的影響

COVID-19疫情對兒科醫療保健市場產生了重大影響。疫情導致非緊急醫療程序和常規檢查被推遲，影響了整體兒科醫療使用率。然而，遠距諮詢和遠端醫療服務的需求激增，為被封鎖在室內的兒童提供了持續的醫療服務。這場疫情也提高了人們對兒童接種疫苗和預防性保健重要性的認知。

預計在預測期內，外科手術部分將成為最大的部分。

由於針對先天性缺陷、創傷和其他需要手術干預的情況的兒科手術數量的增加，預計在預測期內外科手術將佔據最大的市場佔有率。微創手術技術的進步和兒科患者專用手術器械的普及進一步促進了這一領域的成長。人們越來越意識到早期手術介入對於獲得更好的健康結果的重要性，這也支持了對兒科手術的需求。

預計預測期內新生兒（0-28 天）部分的複合年成長率最高。

由於早產率上升和新生兒健康併發症增加導致對新生兒護理的關注度增加，預計新生兒（0-28 天）部分將在預測期內出現最高成長率。新生兒加護病房(NICU) 的進步和新生兒專用醫療設備的普及正在支持這一領域的擴張。此外，政府旨在降低新生兒死亡率和提高新生兒護理品質的措施和計劃進一步推動了對新生兒醫療保健服務的需求。

比最大的地區

預計北美將在預測期內佔據最大的市場佔有率，這得益於該地區完善的醫療保健基礎設施、高昂的醫療保健支出以及主要兒科醫療保健提供者的存在，從而佔據主導地位。此外，兒童慢性病發病率的不斷上升以及兒科專科護理需求的不斷成長正在推動北美市場的成長。政府旨在改善兒童健康和降低嬰兒死亡率的措施和政策進一步支持了兒童保健服務的擴大。

複合年成長率最高的地區

預計預測期內亞太地區將呈現最高的複合年成長率。該地區兒科醫療保健市場的快速成長是由慢性病盛行率的增加、醫療成本的上升以及醫療保健基礎設施的不斷擴大所推動的。中國和印度等國家處於這一成長的前沿，政府採取措施致力於改善兒童健康和降低嬰兒死亡率。家長對兒童預防性保健和定期檢查重要性的認知不斷提高，進一步推動了市場擴張。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球兒科醫療保健市場按治療類型分類

  • 介紹
  • 藥物
  • 外科手術
  • 預防保健
  • 治療
  • 其他

6. 全球兒科醫療保健市場按藥物類型分類

  • 介紹
  • 抗生素
  • 止痛藥和止痛藥
  • 退燒藥
  • 抗過敏藥物
  • 抗發炎藥物
  • 抗病毒藥物
  • 抗驚厥藥
  • 化療藥物

7. 全球兒科醫療保健市場（按年齡層分類）

  • 介紹
  • 新生兒（0-28 天）
  • 嬰兒（1個月至1歲）
  • 嬰兒（1-3歲）
  • 學齡前兒童（3-5歲）
  • 學齡兒童（6-12歲）

8. 全球兒科醫療保健市場（按適應症）

  • 介紹
  • 氣喘和過敏
  • 心臟病
  • 遺傳性疾病
  • 糖尿病
  • 肥胖
  • 其他

9. 全球兒科醫療保健市場（按應用）

  • 介紹
  • 小兒科專科護理
  • 急診及嚴重治療
  • 心理和行為健康
  • 居家醫療和遠端醫療
  • 疾病的治療和管理
  • 其他

第 10 章 全球兒科醫療保健市場（按最終用戶分類）

  • 介紹
  • 醫院
  • 診所和門診中心
  • 研究和學術機構
  • 政府和非政府組織
  • 其他

第 11 章。

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Abbott Laboratories
  • BAYADA Home Health Care
  • Boehringer Ingelheim International GmbH
  • BrightStar Care
  • Eisai Co.
  • Eli Lilly and Company
  • EnViva Paediatric Care
  • Gilead Sciences
  • GlaxosmithklinePlc
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc
  • Sanofi SA
  • Tendercare Home Health
  • The Procter & Gamble Company
  • Viatris
Product Code: SMRC28713

According to Stratistics MRC, the Global Paediatric Healthcare Market is accounted for $14.7 billion in 2024 and is expected to reach $20.0 billion by 2030 growing at a CAGR of 6.4% during the forecast period. Providing medical care, treatment, and preventative services to newborns, kids, and teenagers up to the age of eighteen is the specialty of pediatric healthcare. Neonatal care, vaccinations, illness prevention, and the diagnosis, treatment, and management of long-term problems such as diabetes, asthma, and congenital disorders are all included. Nutritional counselling and immunization programs are important preventive interventions. To provide individualized care, paediatricians, nurses, and specialists work in tandem with parents. Global access to high-quality pediatric care has been enhanced by developments in telemedicine, medical technology, and AI-driven diagnostics.

According to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. Infectious disorders continue to be the primary causes of death among children under the age of five around the world.

Market Dynamics:

Driver:

Increasing prevalence of chronic illnesses

Chronic illnesses among children, such as asthma, diabetes, and obesity conditions require ongoing medical attention and specialized care, leading to a higher demand for paediatric healthcare services. Additionally, early diagnosis and intervention are critical for managing chronic illnesses, further emphasizing the need for advanced diagnostic tools and treatment options. The growing awareness among parents about the importance of regular health check-ups for their children is also contributing to the market's growth.

Restraint:

High treatment costs & limited insurance coverage

Specialized care for children with chronic illnesses or complex medical conditions can be prohibitively expensive, making it difficult for many families to afford the necessary treatments. Furthermore, not all insurance plans provide adequate coverage for paediatric healthcare services, leading to out-of-pocket expenses for families. The financial burden associated with medical treatments can deter parents from seeking timely and appropriate care for their children. Efforts to improve insurance coverage and reduce treatment costs are essential to ensure that all children have access to quality healthcare services.

Opportunity:

Increased awareness of child health & nutrition

Parents and caregivers are becoming more informed about the importance of a balanced diet, regular exercise, and preventive healthcare for their children. This heightened awareness is driving demand for health education programs, nutritional counselling, and wellness services. Schools and community organizations are also playing a role in promoting healthy lifestyle choices among children. As a result, paediatric healthcare providers are expanding their services to include comprehensive health and wellness programs that address the physical, mental, and emotional well-being of children.

Threat:

Shortage of paediatric specialists

The growing demand for paediatricians, paediatric nurses, and other specialized healthcare professionals is not being met with an adequate supply. This shortage can lead to longer wait times for appointments, reduced access to specialized care, and increased workloads for existing healthcare providers. The lack of paediatric specialists can also impact the quality of care provided to children, particularly those with complex medical conditions requiring specialized expertise impeding the market growth.

Covid-19 Impact

The COVID-19 pandemic has had a profound impact on the paediatric healthcare market. The pandemic led to the postponement of non-urgent medical procedures and routine check-ups, affecting overall healthcare utilization for children. However, the need for remote consultations and telehealth services surged, providing continued access to medical care for children during lockdowns. The pandemic also heightened awareness about the importance of vaccinations and preventive healthcare for children.

The surgical procedures segment is expected to be the largest during the forecast period

The surgical procedures segment is expected to account for the largest market share during the forecast period due to increasing number of paediatric surgeries for congenital anomalies, trauma, and other medical conditions requiring surgical intervention. Advances in minimally invasive surgical techniques and the availability of specialized surgical equipment for paediatric patients further contribute to the segment's growth. The rise in awareness about the importance of early surgical intervention for better health outcomes also supports the demand for paediatric surgical procedures.

The neonates (0-28 days) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neonates (0-28 days) segment is predicted to witness the highest growth rate owing to increasing focus on neonatal care, driven by rising preterm birth rates and neonatal health complications, is a key factor contributing to this growth. Advances in neonatal intensive care units (NICUs) and the availability of specialized medical equipment for newborns support the segment's expansion. Additionally, government initiatives and programs aimed at reducing neonatal mortality rates and improving the quality of care for newborns further drive the demand for neonatal healthcare services.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to region's well-established healthcare infrastructure, high healthcare expenditure, and the presence of major paediatric healthcare providers contribute to its dominant position. Additionally, the increasing prevalence of chronic illnesses among children and the rising demand for specialized paediatric care drive the market growth in North America. Government initiatives and policies aimed at improving child health and reducing infant mortality rates further support the expansion of paediatric healthcare services.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR attributed rapid growth of the paediatric healthcare market in this region is driven by the increasing prevalence of chronic illnesses, rising healthcare expenditure, and the expansion of healthcare infrastructure. Countries like China and India are at the forefront of this growth, with government initiatives aimed at improving child health and reducing infant mortality rates. The growing awareness among parents about the importance of preventive healthcare and regular check-ups for children further supports the market expansion.

Key players in the market

Some of the key players in Paediatric Healthcare market include Abbott Laboratories, BAYADA Home Health Care, Boehringer Ingelheim International GmbH, BrightStar Care, Eisai Co., Eli Lilly and Company, EnViva Paediatric Care, Gilead Sciences, GlaxosmithklinePlc, Johnson & Johnson, Novartis International AG, Pfizer Inc, Sanofi S A, Tendercare Home Health, The Procter & Gamble Company and Viatris.

Key Developments:

In January 2025, Eli Lilly and Company and Scorpion Therapeutics, Inc announced a definitive agreement for Lilly to acquire Scorpion's PI3Ka inhibitor program STX-478. STX-478 is a once-daily oral, mutant-selective PI3Ka inhibitor currently being evaluated in a Phase 1/2.

In January 2025, Johnson & Johnson and Intra-Cellular Therapies, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies.

In December 2024, Abbott announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the companies in cases related to continuous glucose monitoring products.

Treatment Types Covered:

  • Medications
  • Surgical Procedures
  • Preventive Care
  • Therapy
  • Other Treatment Types

Drug Types Covered:

  • Antibiotics
  • Analgesics and Pain Medications
  • Antipyretics
  • Antiallergy Drugs
  • Anti-inflammatory Drugs
  • Antiviral Drugs
  • Anticonvulsants
  • Chemotherapy Drugs

Age Groups Covered:

  • Neonates (0-28 days)
  • Infants (1 month - 1 year)
  • Toddlers (1-3 years)
  • Preschoolers (3-5 years)
  • School-aged Children (6-12 years)

Indications Covered:

  • Asthma & Allergies
  • Cardiac Disorders
  • Genetic Disorders
  • Diabetes
  • Obesity
  • Other Indications

Applications Covered:

  • Paediatric Specialty Care
  • Emergency & Critical Care
  • Mental & Behavioural Health
  • Home Healthcare & Telemedicine
  • Disease Treatment & Management
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics & Ambulatory Care Centres
  • Research & Academic Institutions
  • Government & Non-Governmental Organizations
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Paediatric Healthcare Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Medications
  • 5.3 Surgical Procedures
  • 5.4 Preventive Care
  • 5.5 Therapy
  • 5.6 Other Treatment Types

6 Global Paediatric Healthcare Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Antibiotics
  • 6.3 Analgesics and Pain Medications
  • 6.4 Antipyretics
  • 6.5 Antiallergy Drugs
  • 6.6 Anti-inflammatory Drugs
  • 6.7 Antiviral Drugs
  • 6.8 Anticonvulsants
  • 6.9 Chemotherapy Drugs

7 Global Paediatric Healthcare Market, By Age Group

  • 7.1 Introduction
  • 7.2 Neonates (0-28 days)
  • 7.3 Infants (1 month - 1 year)
  • 7.4 Toddlers (1-3 years)
  • 7.5 Preschoolers (3-5 years)
  • 7.6 School-aged Children (6-12 years)

8 Global Paediatric Healthcare Market, By Indication

  • 8.1 Introduction
  • 8.2 Asthma & Allergies
  • 8.3 Cardiac Disorders
  • 8.4 Genetic Disorders
  • 8.5 Diabetes
  • 8.6 Obesity
  • 8.7 Other Indications

9 Global Paediatric Healthcare Market, By Application

  • 9.1 Introduction
  • 9.2 Paediatric Specialty Care
  • 9.3 Emergency & Critical Care
  • 9.4 Mental & Behavioural Health
  • 9.5 Home Healthcare & Telemedicine
  • 9.6 Disease Treatment & Management
  • 9.7 Other Applications

10 Global Paediatric Healthcare Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Clinics & Ambulatory Care Centres
  • 10.4 Research & Academic Institutions
  • 10.5 Government & Non-Governmental Organizations
  • 10.6 Other End Users

11 Global Paediatric Healthcare Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 BAYADA Home Health Care
  • 13.3 Boehringer Ingelheim International GmbH
  • 13.4 BrightStar Care
  • 13.5 Eisai Co.
  • 13.6 Eli Lilly and Company
  • 13.7 EnViva Paediatric Care
  • 13.8 Gilead Sciences
  • 13.9 GlaxosmithklinePlc
  • 13.10 Johnson & Johnson
  • 13.11 Novartis International AG
  • 13.12 Pfizer Inc
  • 13.13 Sanofi S A
  • 13.14 Tendercare Home Health
  • 13.15 The Procter & Gamble Company
  • 13.16 Viatris

List of Tables

  • Table 1 Global Paediatric Healthcare Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Paediatric Healthcare Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Paediatric Healthcare Market Outlook, By Medications (2022-2030) ($MN)
  • Table 4 Global Paediatric Healthcare Market Outlook, By Surgical Procedures (2022-2030) ($MN)
  • Table 5 Global Paediatric Healthcare Market Outlook, By Preventive Care (2022-2030) ($MN)
  • Table 6 Global Paediatric Healthcare Market Outlook, By Therapy (2022-2030) ($MN)
  • Table 7 Global Paediatric Healthcare Market Outlook, By Other Treatment Types (2022-2030) ($MN)
  • Table 8 Global Paediatric Healthcare Market Outlook, By Drug Type (2022-2030) ($MN)
  • Table 9 Global Paediatric Healthcare Market Outlook, By Antibiotics (2022-2030) ($MN)
  • Table 10 Global Paediatric Healthcare Market Outlook, By Analgesics and Pain Medications (2022-2030) ($MN)
  • Table 11 Global Paediatric Healthcare Market Outlook, By Antipyretics (2022-2030) ($MN)
  • Table 12 Global Paediatric Healthcare Market Outlook, By Antiallergy Drugs (2022-2030) ($MN)
  • Table 13 Global Paediatric Healthcare Market Outlook, By Anti-inflammatory Drugs (2022-2030) ($MN)
  • Table 14 Global Paediatric Healthcare Market Outlook, By Antiviral Drugs (2022-2030) ($MN)
  • Table 15 Global Paediatric Healthcare Market Outlook, By Anticonvulsants (2022-2030) ($MN)
  • Table 16 Global Paediatric Healthcare Market Outlook, By Chemotherapy Drugs (2022-2030) ($MN)
  • Table 17 Global Paediatric Healthcare Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 18 Global Paediatric Healthcare Market Outlook, By Neonates (0-28 days) (2022-2030) ($MN)
  • Table 19 Global Paediatric Healthcare Market Outlook, By Infants (1 month - 1 year) (2022-2030) ($MN)
  • Table 20 Global Paediatric Healthcare Market Outlook, By Toddlers (1-3 years) (2022-2030) ($MN)
  • Table 21 Global Paediatric Healthcare Market Outlook, By Preschoolers (3-5 years) (2022-2030) ($MN)
  • Table 22 Global Paediatric Healthcare Market Outlook, By School-aged Children (6-12 years) (2022-2030) ($MN)
  • Table 23 Global Paediatric Healthcare Market Outlook, By Indication (2022-2030) ($MN)
  • Table 24 Global Paediatric Healthcare Market Outlook, By Asthma & Allergies (2022-2030) ($MN)
  • Table 25 Global Paediatric Healthcare Market Outlook, By Cardiac Disorders (2022-2030) ($MN)
  • Table 26 Global Paediatric Healthcare Market Outlook, By Genetic Disorders (2022-2030) ($MN)
  • Table 27 Global Paediatric Healthcare Market Outlook, By Diabetes (2022-2030) ($MN)
  • Table 28 Global Paediatric Healthcare Market Outlook, By Obesity (2022-2030) ($MN)
  • Table 29 Global Paediatric Healthcare Market Outlook, By Other Indications (2022-2030) ($MN)
  • Table 30 Global Paediatric Healthcare Market Outlook, By Application (2022-2030) ($MN)
  • Table 31 Global Paediatric Healthcare Market Outlook, By Paediatric Specialty Care (2022-2030) ($MN)
  • Table 32 Global Paediatric Healthcare Market Outlook, By Emergency & Critical Care (2022-2030) ($MN)
  • Table 33 Global Paediatric Healthcare Market Outlook, By Mental & Behavioural Health (2022-2030) ($MN)
  • Table 34 Global Paediatric Healthcare Market Outlook, By Home Healthcare & Telemedicine (2022-2030) ($MN)
  • Table 35 Global Paediatric Healthcare Market Outlook, By Disease Treatment & Management (2022-2030) ($MN)
  • Table 36 Global Paediatric Healthcare Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 37 Global Paediatric Healthcare Market Outlook, By End User (2022-2030) ($MN)
  • Table 38 Global Paediatric Healthcare Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 39 Global Paediatric Healthcare Market Outlook, By Clinics & Ambulatory Care Centres (2022-2030) ($MN)
  • Table 40 Global Paediatric Healthcare Market Outlook, By Research & Academic Institutions (2022-2030) ($MN)
  • Table 41 Global Paediatric Healthcare Market Outlook, By Government & Non-Governmental Organizations (2022-2030) ($MN)
  • Table 42 Global Paediatric Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.